CLDN18.2

Close
Menu

This is a healthcare professional site

The information contained in the site is intended for US healthcare professionals only. By selecting “Okay” below, you verify that you are a licensed US healthcare professional.

No

Books on bookshelves with overlay of abstract gray concentric circles

CLDN18.2 resources

Download additional resources to learn more about how to consistently test, interpret, and report CLDN18.2 in G/GEJ cancer.

CLDN18.2 Reporting Template

Download the guidance from our expert committee.

RING Trial Poster

Learn more about cross-platform and antibody comparison of CLDN18 expression.

IHC Assay Guide

Explore our expert-recommended IHC Implementation Guide to help you set up a new biomarker assay in your lab.

eLearning Center

Access a self-guided CLDN18.2 educational program.

Visit the eLearning Site

ECP Testing Presentation
2023

Analytical and Clinical Performance of the VENTANA CLDN18 (43-14A) RxDx Assay in Gastric and Gastroesophageal Junction Adenocarcinoma Tissue Samples for Patient Identification in Two Phase 3 Trials of Zolbetuximab

Access to and use of this Site is subject to the Terms of use available here. This Site was developed and is maintained by Astellas. Astellas and the flying star logo are registered trademarks of Astellas Pharma Inc.

All case reviews and consensus scoring has been independently conducted by the members of the KEE Expert Committee.

©2024 Astellas Pharma, Inc. All rights reserved.

MAT-IT-NON-2024-00138 08/24